McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements

by McKesson Ventures | Jan 22, 2024 | Press Releases

On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional...

Komodo Health Unveils New Annual Report Illuminating the State of Data Mining in Life Sciences

by McKesson Ventures | Jan 9, 2024 | Portfolio News

In a new survey, Komodo Health benchmarked the state of real-world data (RWD) and analytics. The survey, which is the first of its kind, explores the complexities of generating meaningful insights and the challenges life sciences teams face in making forward progress....

PM360 Announces the Selections for its 12th Annual Innovations Issue

by McKesson Ventures | Dec 14, 2023 | Press Releases

On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of...

ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform

by McKesson Ventures | Dec 8, 2023 | Press Releases

Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple...

New Study Shows Point-of-care Genetics May Improve Uptake, Reduce Racial Disparities

by McKesson Ventures | Dec 7, 2023 | Press Releases

On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This...
Page 8 of 144« First«...678910...203040...»Last »

Recent Posts

  • Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings